Prognostic Value Of Preoperative Systemic Inflammatory Biomarkers In Patients With Gallbladder Cancer And The Establishment Of A Nomogram

References

• Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168–181. doi:10.1634/theoncologist.2009-030220147507
   PubMed Web of Science ®Google Scholar
• Baiu I, Visser B. Gallbladder cancer. JAMA. 2018;320(12):1294. doi:10.1001/jama.2018.1181530264121
   PubMedGoogle Scholar
• Hemminki K, Hemminki A, Forsti A, Sundquist K, Li X. Genetics of gallbladder cancer. Lancet Oncol. 2017;18(6):e296. doi:10.1016/S1470-2045(17)30072-428593851
   PubMedGoogle Scholar
• Chan E, Berlin J. Biliary tract cancers: understudied and poorly understood. J Clin Oncol. 2015;33(16):1845–1848. doi:10.1200/JCO.2014.59.759125918294
   PubMed Web of Science ®Google Scholar
• Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012;21(4):e183–e191. doi:10.1016/j.suronc.2012.08.00223025910
   PubMed Web of Science ®Google Scholar
• Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109. doi:10.2147/CLEP.S3735724634588
   PubMed Web of Science ®Google Scholar
• Barreto SG, Dutt A, Sirohi B, Shrikhande SV. Gallbladder cancer: a journey of a thousand steps. Future Oncol. 2018;14(13):1299–1306. doi:10.2217/fon-2017-057629722272
   PubMed Web of Science ®Google Scholar
• Cronin KA, Ries LA, Edwards BK, Surveillance T. Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Cancer. 2014;120 Suppl 23:3755–3757. doi:10.1002/cncr.2904925412387
   PubMedGoogle Scholar
• SJ H, HK W, MA J, Watson M, Richardson LC. Gallbladder Cancer Incidence and Mortality, United States 1999–2011. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1319–1326. doi:10.1158/1055-9965.EPI-15-019926070529
   PubMed Web of Science ®Google Scholar
• Sun Y, Song W, Hou Q, Li J, Guo H. Gallbladder perforation: a rare complication of postoperative chemotherapy of gastric cancer. World J Surg Oncol. 2015;13:245. doi:10.1186/s12957-015-0659-626271278
   PubMed Web of Science ®Google Scholar
• Kakaei F, Beheshtirouy S, Nejatollahi SM, Zarrintan S, Mafi MR. Surgical treatment of gallbladder carcinoma: a critical review. Updates Surg. 2015;67(4):339–351. doi:10.1007/s13304-015-0328-x26563387
   PubMedGoogle Scholar
• Bal MM, Ramadwar M, Deodhar K, Shrikhande S. Pathology of gallbladder carcinoma: current understanding and new perspectives. Pathol Oncol Res. 2015;21(3):509–525. doi:10.1007/s12253-014-9886-325618479
   PubMed Web of Science ®Google Scholar
• Rakic M, Patrlj L, Kopljar M, et al. Gallbladder cancer. Hepatobiliary Surg Nutr. 2014;3(5):221–226. doi:10.3978/j.issn.2304-3881.2014.09.0325392833
   PubMedGoogle Scholar
• Bai Y, Liu ZS, Xiong JP, et al. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol. 2018;24(45):5167–5178. doi:10.3748/wjg.v24.i45.516730568393
   PubMed Web of Science ®Google Scholar
• Yifan T, Zheyong L, Miaoqin C, Liang S, Xiujun C. A predictive model for survival of gallbladder adenocarcinoma. Surg Oncol. 2018;27(3):365–372. doi:10.1016/j.suronc.2018.05.00730217289
   PubMed Web of Science ®Google Scholar
• Abe T, Amano H, Hanada K, et al. Preoperative systemic inflammation and complications affect long-term gallbladder carcinoma outcomes following surgery with curative intent. Anticancer Res. 2016;36(9):4887–4894. doi:10.21873/anticanres.1105327630345
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-325281468
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230. doi:10.1016/j.critrevonc.2013.03.01023602134
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang R, Chen W, et al. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma. HPB (Oxford). 2016;18(7):600–607. doi:10.1016/j.hpb.2016.03.60827346141
   PubMed Web of Science ®Google Scholar
• Duan J, Pan L, Yang M. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: a meta-analysis. Medicine (Baltimore). 2018;97(49):e13340. doi:10.1097/MD.000000000001334030544398
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204–1212. doi:10.1158/1055-9965.EPI-14-014624793958
   PubMed Web of Science ®Google Scholar
• Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):971–978. doi:10.1016/j.ctrv.2015.10.00326481060
   PubMed Web of Science ®Google Scholar
• Chen C, Geng Z, Shen H, et al. Long-term outcomes and prognostic factors in advanced gallbladder cancer: focus on the advanced t stage. PLoS One. 2016;11(11):e0166361. doi:10.1371/journal.pone.016636127846279
   PubMed Web of Science ®Google Scholar
• Nigam J, Chandra A, Kazmi HR, Parmar D, Singh D, Gupta V. Prognostic significance of survivin in resected gallbladder cancer. The Journal of Surgical Research. 2015;194(1):57–62. doi:10.1016/j.jss.2014.07.05425472573
   PubMed Web of Science ®Google Scholar
• Sherman M. Hepatocellular carcinoma: screening and staging. Clin Liver Dis. 2011;15(2):323–334, vii-x. doi:10.1016/j.cld.2011.03.003
   PubMed Web of Science ®Google Scholar
• Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med. 2010;42(3):161–170. doi:10.3109/0785389090340575320384432
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–1081. doi:10.1093/carcin/bgp12719468060
   PubMed Web of Science ®Google Scholar
• Locatelli M, Ferrero S, Martinelli Boneschi F, et al. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas. J Neuroimmunol. 2013;260(1–2):99–106. doi:10.1016/j.jneuroim.2013.04.00923664694
   PubMed Web of Science ®Google Scholar
• Pinato DJ. Cancer-related inflammation: an emerging prognostic domain in metastatic castration-resistant prostate carcinoma. Cancer. 2014;120(21):3272–3274. doi:10.1002/cncr.2888924995642
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–148. doi:10.1016/j.immuni.2004.07.01715308095
   PubMed Web of Science ®Google Scholar
• Adams S, Goldstein LJ, Sparano JA, Demaria S, Badve SS. Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC). Oncoimmunology. 2015;4(9):e985930. doi:10.1080/2162402X.2015.100837126405612
   PubMed Web of Science ®Google Scholar
• Fogar P, Sperti C, Basso D, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32(1):22–28. doi:10.1097/01.mpa.0000188305.90290.5016340740
   PubMed Web of Science ®Google Scholar
• De Giorgi U, Mego M, Scarpi E, et al. Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer. 2012;12(4):264–269. doi:10.1016/j.clbc.2012.04.00422591634
   PubMed Web of Science ®Google Scholar
• Pattison CW, Woods KL, Morrison JM. Lymphocytopenia as an independent predictor of early recurrence in breast cancer. Br J Cancer. 1987;55(1):75–76. doi:10.1038/bjc.1987.153814479
   PubMed Web of Science ®Google Scholar
• Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105(1):93–103. doi:10.1038/bjc.2011.18921629244
   PubMed Web of Science ®Google Scholar
• Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71–78. doi:10.1038/nrc125614708027
   PubMed Web of Science ®Google Scholar
• Hagemann T, Lawrence T. Investigating macrophage and malignant cell interactions in vitro. Methods Mol Biol. 2009;512:325–332. doi:10.1007/978-1-60327-530-9_1819347286
   PubMedGoogle Scholar
• Mano Y, Aishima S, Fujita N, et al. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Pathobiology. 2013;80(3):146–154. doi:10.1159/00034619623364389
   PubMed Web of Science ®Google Scholar
• Evani SJ, Prabhu RG, Gnanaruban V, Finol EA, Ramasubramanian AK. Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. Faseb J. 2013;27(8):3017–3029. doi:10.1096/fj.12-22482423616566
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Allavena P, Garlanda C, Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol. 2009;70(5):325–330. doi:10.1016/j.humimm.2009.02.00819236898
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431–446. doi:10.1038/nrc.2016.5227282249
   PubMed Web of Science ®Google Scholar
• Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest. 2010;120(4):1151–1164. doi:10.1172/JCI3722320237412
   PubMed Web of Science ®Google Scholar
• Schiffmann LM, Fritsch M, Gebauer F, et al. Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer. Br J Cancer. 2019;120(1):69–78. doi:10.1038/s41416-018-0198-330377339
   PubMed Web of Science ®Google Scholar
• Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71(7):2411–2416. doi:10.1158/0008-5472.CAN-10-258321427354
   PubMed Web of Science ®Google Scholar
• Parikh K, Kumar A, Ahmed J, et al. Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer. Cancer Immunol Immunother. 2018;67(9):1365–1370. doi:10.1007/s00262-018-2192-229968154
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003;32(3):201–215.12916709
   PubMed Web of Science ®Google Scholar
• Suzana S, Boon PC, Chan PP, Normah CD. Malnutrition risk and its association with appetite, functional and psychosocial status among elderly Malays in an agricultural settlement. Malays J Nutr. 2013;19(1):65–75.24800385
   PubMedGoogle Scholar